Astonea Labs (BOM:544409) ROCE %: 28.58% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544409 Astonea Labs Ltd BOM:544409
12 GF Score
Price ₹273.75
! 4 Warning Signs
View Full Analysis

What is Astonea Labs ROCE %?

Astonea Labs BOM:544409 +1.01% 12 ROCE % is 28.58% as of Mar. 2026. GuruFocus rates BOM:544409 with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Astonea Labs's annualized ROCE % for the quarter that ended in Mar. 2026 was 28.58%.

Astonea Labs  (BOM:544409) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Astonea Labs ROCE % Related Terms

Astonea Labs ROCE % Historical Data

* Premium members only.

The historical data trend for Astonea Labs's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astonea Labs ROCE % Chart

Astonea Labs Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
6.83 11.55 26.99 29.80 15.35

Astonea Labs Quarterly Data
Mar22 Mar23 Mar24 Dec24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial 0.00 38.02 26.14 0.00 28.58
BOM:544409
12GF Score
Astonea Labs Ltd BOM:544409
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astonea Labs ROCE % Calculation

Astonea Labs's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=89.58/( ( (1033.807 - 650.018) + (1462.597 - 678.878) )/ 2 )
=89.58/( (383.789+783.719)/ 2 )
=89.58/583.754
=15.35 %

Astonea Labs's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=222.88/( ( (1218.153 - 442.064) + (1462.597 - 678.878) )/ 2 )
=222.88/( ( 776.089 + 783.719 )/ 2 )
=222.88/779.904
=28.58 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 28.58% mean?
Astonea Labs (BOM:544409) has a ROCE % of 28.58% as of Mar. 2026.
Is Astonea Labs' ROCE % too high?
Astonea Labs' current ROCE % is 28.58%. The Drug Manufacturers industry median ROCE % is 7.03. Astonea Labs' value of 28.58% is 306.5% above this industry median. Overall, Astonea Labs has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Astonea Labs' ROCE % compare to ZTS?
Astonea Labs' ROCE % of 28.58% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Astonea Labs' value of 28.58% is 306.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astonea Labs's current ROCE % of 28.58% is 306.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astonea Labs's current ROCE % is 28.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astonea Labs stock overvalued right now?
Astonea Labs (BOM:544409) has a current ROCE % of 28.58%. The current ROCE % is 28.58% and 306.5% above the Drug Manufacturers industry median of 7.03. Astonea Labs' overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Astonea Labs (BOM:544409), the current ROCE % is 28.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Astonea Labs Business Description

Address SCO 186-187, 2nd Floor, Cabin No. 306, SECTOR 8-C, Sector 8, Chandigarh, HR, IND, 160009
Astonea Labs Ltd is an India-based pharmaceutical and cosmetics company engaged in the manufacturing and development of healthcare and personal care products. The Company operates in the pharmaceuticals and cosmetics & personal care space, offering products that include generic medicines, OTC products, specialty therapeutics, nutraceuticals, and biosimilars, as well as skincare, haircare, anti-aging, ethical, and organic cosmetic products, supported by in-house research and development and contract manufacturing services. Its business activities are organized across key segments comprising Pharmaceuticals, Cosmetics & Personal Care, R&D & Innovation, and Contract Manufacturing (CDMO).
12GF Score

Get the complete analysis for BOM:544409

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹273.75
Price